Eur J Pharmacol 954:175896
The idea behind creating BPC-157 Arginate was to address the primary limitation of the acetate version: its fragility
Most patients experience a gradual return of appetite within 2 to 4 weeks after their final dose, though the speed varies based on genetics, lifestyle, and how long you remained on medication
And give someone 275 mg of it, and GLP-1 secretion is stimulated
Thus, in rats with occluded blood vessels, at 1 and 24 h, BPC 157 demonstrated a particular specificity within the pathways (at least, Egr, Nos, Srf, Vegfr, Akt1, Plc , and Kras ) and vessels involved (Vukojevic et al., 2018)
Mantovani, G